LUCD (Lucid Diagnostics Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Lucid Diagnostics Inc. Common Stock (LUCD) is a publicly traded Healthcare sector company. As of May 21, 2026, LUCD trades at $1.00 with a market cap of $182.19M and a P/E ratio of -1.46. LUCD moved +5.60% today. Year to date, LUCD is -11.50%; over the trailing twelve months it is -23.08%. Its 52-week range spans $0.75 to $1.80. Analyst consensus is strong buy with an average price target of $3.90. Rallies surfaces LUCD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns LUCD stock?
Hedge funds tracked by Rallies that own LUCD include Berkshire Asset. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Lucid Diagnostics Inc. Common Stock.
LUCD Key Metrics
Key financial metrics for LUCD
Metric
Value
Price
$1.00
Market Cap
$182.19M
P/E Ratio
-1.46
EPS
$-0.69
Dividend Yield
0.00%
52-Week High
$1.80
52-Week Low
$0.75
Volume
1.03K
Avg Volume
0
Revenue (TTM)
$4.71M
Net Income
$-58.01M
Gross Margin
-41.73%
Top Hedge Funds Holding LUCD
Berkshire Asset holds 20.00K shares of LUCD, changed +0.00% as of Sep 30, 2025.
Hedge funds tracked by Rallies that own LUCD include Berkshire Asset. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Lucid Diagnostics Inc. Common Stock.
Does Rallies show 13F holders for LUCD?
Yes. Rallies tracks hedge fund and 13F ownership data for LUCD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is LUCD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LUCD. It does not provide personalized investment advice.
